Clinical Trials Logo

Metabolic Diseases clinical trials

View clinical trials related to Metabolic Diseases.

Filter by:

NCT ID: NCT05499585 Recruiting - Clinical trials for Non-Alcoholic Fatty Liver Disease

Treating Pediatric NAFLD With Nutrition

Start date: September 12, 2022
Phase: N/A
Study type: Interventional

This is a proof of concept clinical trial to compare daily intake of at least 20 grams of whole dairy fat vs habitual diet on hepatic steatosis in children with NAFLD.

NCT ID: NCT05495607 Completed - Sepsis Clinical Trials

Continous Renal Replacement Therapy With the CARPEDIEM® in a French National Cohort of 25 Neonates and Small Infants

Start date: December 1, 2018
Phase:
Study type: Observational

Historically, CKRT and hemodialysis were performed in small infants and newborns with devices developed for adults with high rates of complications and mortality. We aim to retrospectively report the first multicenter French experience of CARPEDIEM® use and evaluate the efficacy, feasibility, outcomes, and technical considerations of this new device in a population of neonates and small infant. Compared to adult's device continuous renal replacement therapy with an adapted machine allowed successful blood purification without severe complications even in low birth weight neonates.

NCT ID: NCT05492279 Completed - Inflammation Clinical Trials

Is Sheep Ghee Cardioprotective?

Start date: February 1, 2020
Phase: N/A
Study type: Interventional

Normal volunteers were randomly received Sheep ghee or sunflower oil, and before and after the study lipid profile and HS-CRP were measured.

NCT ID: NCT05484999 Active, not recruiting - Clinical trials for Postpartum Depression

The Maternal Well-Being Study

MWB
Start date: May 16, 2022
Phase: N/A
Study type: Interventional

This project aims to understand the local feasibility and acceptability of MamaMeals (a home-delivered nutritious, postpartum meal delivery program) and MamaMatters (a moderated social media-based peer support group) among peripartum women who are eligible for federal supplemental nutrition assistance programs such as The Special Supplemental Nutrition Program for Women, Infants and Children (WIC) or Supplemental Nutrition Assistance Program (SNAP). The investigators will conduct a prospective randomized controlled trial (RCT) of these two interventions among postpartum individuals. Analyses will be performed to determine the relative risk of postpartum depressive or anxiety symptoms (primary outcome) and overall well-being and maternal/infant health (secondary/exploratory outcomes) between groups. Findings from this pilot intervention study will inform a future, large RCT exploring the effectiveness of MamaMeals and/or MamaMatters on reducing postpartum mental health symptoms and cardiovascular morbidity among individuals with food insecurity during and after pregnancy.

NCT ID: NCT05476627 Recruiting - Obesity Clinical Trials

Risk Factors and Multiomics Study of Chronic Kidney Disease Caused by Metabolic Diseases

Start date: July 1, 2022
Phase:
Study type: Observational

With the development of China's economy, people's living standard have improved, and the dietary structure have changed. Metabolic diseases, such as hypertension, diabetes, hyperuricemia and obesity have gradually become an important health burden in China. The pathophysiological mechanism of renal injury caused by metabolic diseases has always been a hotspot of research. Currently, it is believed that various mechanisms including the activation of Renin-Angiotensin-Aldosterone System, vascular endothelial dysfunction, oxidative stress and inflammatory process may be involved. Although there are differences in renal pathological manifestations caused by different metabolic diseases, the kidney will eventually present ischemic changes and fibrosis with the progression of the disease. So there must be some common pathogenesis. This study is designed to build a disease cohort of patients with chronic kidney disease caused by metabolic diseases, to identify risk factors leading to disease progression and to explore biomarkers for early diagnosis and treatment of kidney damage.

NCT ID: NCT05476536 Recruiting - Metabolic Disease Clinical Trials

Effectiveness of Technology for Metabolic Diseases Combined Sarcopenia

Start date: February 15, 2023
Phase: N/A
Study type: Interventional

The lifestyle program intervention program focusing on healthy dietary habit and exercise effectively prevents metabolic syndrome, sarcopenia or frailty. Thus, the purpose of this study was to assess the efficacy of intervention program on metabolic syndrome subjects in Taiwan.

NCT ID: NCT05473546 Completed - Critical Illness Clinical Trials

Diarrhea and Stipsis in Critically Ill Patients (NUTRITI)

NUTRITI
Start date: October 11, 2019
Phase:
Study type: Observational

This study prospectively observed the complications intended as diarrhea or sti-sis that critically ill patients developed within 7 days after ICU admission. In addition, secondary aims investigated through bioimpedenziometry the loss of lean body mass and changes in phase angle during the same period of ICU stay.

NCT ID: NCT05461144 Not yet recruiting - Metabolic Disease Clinical Trials

AI Models for Non-invasive Glycaemic Event Detection Using ECG in Type 1 Diabetics

Start date: September 30, 2022
Phase:
Study type: Observational

This observational study aims to recruit up to thirty T1DM patients from a diabetic outpatient clinic at the University Hospital Coventry and Warwickshire for a two-phase study. The first phase involves attending an inpatient protocol for up to thirty-six hours in a calorimetry room at the Human Metabolism Research Unit under controlled conditions, followed by a phase of free-living, for up to three days, in which participants will go about their normal daily activities without restriction. Throughout the study, the participants will wear commercially available wearable sensors to measure and record physiological signals (e.g., electrocardiogram and continuous glucose monitor). Data collected will be used to develop and validate an AI model using state-of-the-art deep-learning methods for the purpose of non-invasive glycaemic event detection.

NCT ID: NCT05456854 Recruiting - Metabolic Disease Clinical Trials

Evaluation of Kisspeptin Stimulated Insulin Secretion With Hyperglycemic Clamp

Start date: June 3, 2022
Phase: Phase 1
Study type: Interventional

The goal of this study is to understand how exogenous kisspeptin affects metabolism by evaluating responses to an hyperglycemic clamp

NCT ID: NCT05446753 Recruiting - Clinical trials for Cardiovascular Diseases

Singapore Healthy Alternative Protein Evaluation Study

SHAPES
Start date: June 17, 2022
Phase: N/A
Study type: Interventional

The overall aim of this randomized controlled trial is to investigate the effects of consuming a Plant-Based Meat alternative Diet (PBMD) compared to an Animal-Based Meat Diet (ABMD) on cardiometabolic health and protein homeostasis in Chinese men and women in Singapore. This will be achieved through the following specific objectives: (1) To evaluate the effects of dietary protein source on metabolic health and glycemic control(2) To evaluate the effects of dietary protein source on risk factors of cardiovascular diseases (3) To evaluate the effects of dietary protein source on protein homeostasis and metabolism.